ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,245 | -76.5% | 44,348 | -70.4% | 0.08% | -81.1% |
| Q2 2023 | $1,258,500 | +212.3% | 150,000 | +48.9% | 0.44% | +201.4% |
| Q4 2021 | $403,000 | -76.8% | 100,759 | -49.0% | 0.15% | -66.7% |
| Q3 2021 | $1,736,000 | -23.4% | 197,759 | -1.1% | 0.44% | -46.0% |
| Q2 2021 | $2,266,000 | -36.4% | 200,000 | -33.3% | 0.81% | -33.0% |
| Q1 2021 | $3,564,000 | +419.5% | 300,000 | +200.0% | 1.21% | +232.4% |
| Q4 2020 | $686,000 | – | 100,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |